373 related articles for article (PubMed ID: 17911404)
1. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.
Krajisnik T; Björklund P; Marsell R; Ljunggren O; Akerström G; Jonsson KB; Westin G; Larsson TE
J Endocrinol; 2007 Oct; 195(1):125-31. PubMed ID: 17911404
[TBL] [Abstract][Full Text] [Related]
2. Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells.
Segersten U; Björklund P; Hellman P; Akerström G; Westin G
Clin Endocrinol (Oxf); 2007 Mar; 66(3):399-404. PubMed ID: 17302875
[TBL] [Abstract][Full Text] [Related]
3. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.
Ritter CS; Armbrecht HJ; Slatopolsky E; Brown AJ
Kidney Int; 2006 Aug; 70(4):654-9. PubMed ID: 16807549
[TBL] [Abstract][Full Text] [Related]
4. Regulation of 25-hydroxyvitamin D-1-hydroxylase and 24-hydroxylase in keratinocytes by PTH and FGF23.
Wu W; Fan H; Jiang Y; Liao L; Li L; Zhao J; Zhang H; Shrestha C; Xie Z
Exp Dermatol; 2018 Nov; 27(11):1201-1209. PubMed ID: 30066343
[TBL] [Abstract][Full Text] [Related]
5. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
Brown AJ; Ritter CS; Knutson JC; Strugnell SA
Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro.
Perwad F; Zhang MY; Tenenhouse HS; Portale AA
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1577-83. PubMed ID: 17699549
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH.
Saji F; Shigematsu T; Sakaguchi T; Ohya M; Orita H; Maeda Y; Ooura M; Mima T; Negi S
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1212-7. PubMed ID: 20739393
[TBL] [Abstract][Full Text] [Related]
8. FGF23 fails to inhibit uremic parathyroid glands.
Canalejo R; Canalejo A; Martinez-Moreno JM; Rodriguez-Ortiz ME; Estepa JC; Mendoza FJ; Munoz-Castaneda JR; Shalhoub V; Almaden Y; Rodriguez M
J Am Soc Nephrol; 2010 Jul; 21(7):1125-35. PubMed ID: 20431039
[TBL] [Abstract][Full Text] [Related]
9. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
[TBL] [Abstract][Full Text] [Related]
10. Xeno-Klotho Inhibits Parathyroid Hormone Signaling.
Takenaka T; Inoue T; Miyazaki T; Hayashi M; Suzuki H
J Bone Miner Res; 2016 Feb; 31(2):455-62. PubMed ID: 26287968
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
[TBL] [Abstract][Full Text] [Related]
12. Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System.
Latic N; Erben RG
Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501215
[TBL] [Abstract][Full Text] [Related]
13. The parathyroid is a target organ for FGF23 in rats.
Ben-Dov IZ; Galitzer H; Lavi-Moshayoff V; Goetz R; Kuro-o M; Mohammadi M; Sirkis R; Naveh-Many T; Silver J
J Clin Invest; 2007 Dec; 117(12):4003-8. PubMed ID: 17992255
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
Marsell R; Grundberg E; Krajisnik T; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE
Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826
[TBL] [Abstract][Full Text] [Related]
15. miR-129 Blocks Secondary Hyperparathyroidism-Inducing Fgf23/αKlotho Signaling in Mice with Chronic Kidney Disease.
Xu M; Li H; Bai Y; He J; Chen R; An N; Li Y; Dong Y
Am J Med Sci; 2021 May; 361(5):624-634. PubMed ID: 33781552
[TBL] [Abstract][Full Text] [Related]
16. Role of the vitamin D receptor in FGF23 action on phosphate metabolism.
Inoue Y; Segawa H; Kaneko I; Yamanaka S; Kusano K; Kawakami E; Furutani J; Ito M; Kuwahata M; Saito H; Fukushima N; Kato S; Kanayama HO; Miyamoto K
Biochem J; 2005 Aug; 390(Pt 1):325-31. PubMed ID: 15885032
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.
Galitzer H; Ben-Dov IZ; Silver J; Naveh-Many T
Kidney Int; 2010 Feb; 77(3):211-8. PubMed ID: 20016468
[TBL] [Abstract][Full Text] [Related]
18. Regulation of fibroblast growth factor 23 production in bone in uremic rats.
Saji F; Shiizaki K; Shimada S; Okada T; Kunimoto K; Sakaguchi T; Hatamura I; Shigematsu T
Nephron Physiol; 2009; 111(4):p59-66. PubMed ID: 19339809
[TBL] [Abstract][Full Text] [Related]
19. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
Sapir-Koren R; Livshits G
Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
[TBL] [Abstract][Full Text] [Related]
20. FGF23 and the parathyroid glands.
Silver J; Naveh-Many T
Pediatr Nephrol; 2010 Nov; 25(11):2241-5. PubMed ID: 20526631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
